What is Immunome's PP&E (net)?

Immunome (IMNM) reported PP&E (net) of $17.08M in Q1 2026.

How has Immunome's PP&E (net) changed year-over-year?

Immunome's PP&E (net) increased by 55.9% year-over-year, from $10.95M to $17.08M.

What is the long-term trend for Immunome's PP&E (net)?

Over 5 years (2020 to 2025), Immunome's PP&E (net) has grown at a 57.1% compound annual growth rate (CAGR), from $1.53M to $14.64M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Immunome IMNM PP&E (Net)

PP&E (Net) at other companies

PfizerPFE

$19.4B+5.8%

Arcus BiosciencesRCUS

$38M-17.4%

Nuvation BioNUVB

$535K-4.8%

IDEAYA Biosciences, Inc.IDYA

$8.63M-2.7%

ImmunityBio, Inc.IBRX

$112.79M-16.6%

Summit TherapeuticsSMMT

$1.66M+155%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's PP&E (net)?: Immunome (IMNM) reported PP&E (net) of $17.08M in Q1 2026.
How has Immunome's PP&E (net) changed year-over-year?: Immunome's PP&E (net) increased by 55.9% year-over-year, from $10.95M to $17.08M.
What is the long-term trend for Immunome's PP&E (net)?: Over 5 years (2020 to 2025), Immunome's PP&E (net) has grown at a 57.1% compound annual growth rate (CAGR), from $1.53M to $14.64M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.